292 related articles for article (PubMed ID: 34181896)
1. Paradigm shift from tubal ligation to opportunistic salpingectomy at cesarean delivery in the United States.
Mandelbaum RS; Matsuzaki S; Sangara RN; Klar M; Matsushima K; Roman LD; Paulson RJ; Wright JD; Matsuo K
Am J Obstet Gynecol; 2021 Oct; 225(4):399.e1-399.e32. PubMed ID: 34181896
[TBL] [Abstract][Full Text] [Related]
2. Cost-effectiveness of opportunistic salpingectomy vs tubal ligation at the time of cesarean delivery.
Venkatesh KK; Clark LH; Stamilio DM
Am J Obstet Gynecol; 2019 Jan; 220(1):106.e1-106.e10. PubMed ID: 30170036
[TBL] [Abstract][Full Text] [Related]
3. The performance and safety of bilateral salpingectomy for ovarian cancer prevention in the United States.
Hanley GE; McAlpine JN; Pearce CL; Miller D
Am J Obstet Gynecol; 2017 Mar; 216(3):270.e1-270.e9. PubMed ID: 27810554
[TBL] [Abstract][Full Text] [Related]
4. The impact of opportunistic salpingectomy on ovarian cancer mortality and healthcare costs: a call for universal insurance coverage.
Naumann RW; Hughes BN; Brown J; Drury LK; Herzog TJ
Am J Obstet Gynecol; 2021 Oct; 225(4):397.e1-397.e6. PubMed ID: 33798477
[TBL] [Abstract][Full Text] [Related]
5. Extending the safety evidence for opportunistic salpingectomy in prevention of ovarian cancer: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; Finlayson SJ; Huntsman DG; Miller D; McAlpine JN
Am J Obstet Gynecol; 2018 Aug; 219(2):172.e1-172.e8. PubMed ID: 29852159
[TBL] [Abstract][Full Text] [Related]
6. The rapid adoption of opportunistic salpingectomy at the time of hysterectomy for benign gynecologic disease in the United States.
Mandelbaum RS; Adams CL; Yoshihara K; Nusbaum DJ; Matsuzaki S; Matsushima K; Klar M; Paulson RJ; Roman LD; Wright JD; Matsuo K
Am J Obstet Gynecol; 2020 Nov; 223(5):721.e1-721.e18. PubMed ID: 32360846
[TBL] [Abstract][Full Text] [Related]
7. Racial Disparities in Sterilization Procedure Performed at Time of Cesarean Section.
Walheim LK; Hong CX; Hamm RF
Am J Perinatol; 2024 May; 41(S 01):e934-e938. PubMed ID: 36351447
[TBL] [Abstract][Full Text] [Related]
8. Examining indicators of early menopause following opportunistic salpingectomy: a cohort study from British Columbia, Canada.
Hanley GE; Kwon JS; McAlpine JN; Huntsman DG; Finlayson SJ; Miller D
Am J Obstet Gynecol; 2020 Aug; 223(2):221.e1-221.e11. PubMed ID: 32067967
[TBL] [Abstract][Full Text] [Related]
9. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
10. The cost-effectiveness of opportunistic salpingectomy versus standard tubal ligation at the time of cesarean delivery for ovarian cancer risk reduction.
Subramaniam A; Einerson BD; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Gynecol Oncol; 2019 Jan; 152(1):127-132. PubMed ID: 30477808
[TBL] [Abstract][Full Text] [Related]
11. Benefits and Risks of Bilateral Salpingectomy Compared With Standard Tubal Ligation During Cesarean Delivery for Permanent Postpartum Contraception.
Luke S; Addae-Konadu K; Davidson B; Kuller J; Dotters-Katz S
Obstet Gynecol Surv; 2022 Mar; 77(3):167-173. PubMed ID: 35275215
[TBL] [Abstract][Full Text] [Related]
12. Postpartum Permanent Sterilization: Could Bilateral Salpingectomy Replace Bilateral Tubal Ligation?
Danis RB; Della Badia CR; Richard SD
J Minim Invasive Gynecol; 2016; 23(6):928-32. PubMed ID: 27234430
[TBL] [Abstract][Full Text] [Related]
13. Postpartum Opportunistic Salpingectomy Compared With Bilateral Tubal Ligation After Vaginal Delivery for Ovarian Cancer Risk Reduction: A Cost-Effectiveness Analysis.
Wagar MK; Forlines GL; Moellman N; Carlson A; Matthews M; Williams M
Obstet Gynecol; 2023 Apr; 141(4):819-827. PubMed ID: 36897130
[TBL] [Abstract][Full Text] [Related]
14. Opportunistic salpingectomy: uptake, risks, and complications of a regional initiative for ovarian cancer prevention.
McAlpine JN; Hanley GE; Woo MM; Tone AA; Rozenberg N; Swenerton KD; Gilks CB; Finlayson SJ; Huntsman DG; Miller DM;
Am J Obstet Gynecol; 2014 May; 210(5):471.e1-11. PubMed ID: 24412119
[TBL] [Abstract][Full Text] [Related]
15. Ovarian reserve following cesarean section with salpingectomy vs tubal ligation: a randomized trial.
Ganer Herman H; Gluck O; Keidar R; Kerner R; Kovo M; Levran D; Bar J; Sagiv R
Am J Obstet Gynecol; 2017 Oct; 217(4):472.e1-472.e6. PubMed ID: 28455082
[TBL] [Abstract][Full Text] [Related]
16. Feasibility of Complete Salpingectomy Compared With Standard Postpartum Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.
Subramaniam A; Blanchard CT; Erickson BK; Szychowski J; Leath CA; Biggio JR; Huh WK
Obstet Gynecol; 2018 Jul; 132(1):20-27. PubMed ID: 29889762
[TBL] [Abstract][Full Text] [Related]
17. Salpingectomy Compared With Tubal Ligation at Cesarean Delivery: A Randomized Controlled Trial.
Garcia C; Moskowitz OM; Chisholm CA; Duska LR; Warren AL; Lyons GR; Pettit KE
Obstet Gynecol; 2018 Jul; 132(1):29-34. PubMed ID: 29889755
[TBL] [Abstract][Full Text] [Related]
18. Complete salpingectomy versus tubal ligation during cesarean section: a systematic review and meta-analysis.
Yang M; Du Y; Hu Y
J Matern Fetal Neonatal Med; 2021 Nov; 34(22):3794-3802. PubMed ID: 31752570
[TBL] [Abstract][Full Text] [Related]
19. Frequency and characteristics associated with opportunistic salpingectomy at cesarean delivery: A retrospective chart review.
Desravines N; Brenner T; Venkatesh K; Stuart G
Contraception; 2021 Mar; 103(3):203-207. PubMed ID: 33345975
[TBL] [Abstract][Full Text] [Related]
20. Racial and ethnic differences in the adoption of opportunistic salpingectomy for ovarian cancer prevention in the United States.
Karia PS; Huang Y; Tehranifar P; Visvanathan K; Wright JD; Genkinger JM
Am J Obstet Gynecol; 2022 Aug; 227(2):257.e1-257.e22. PubMed ID: 35489439
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
